1
项与 CLL-1 CAR-NK Cell(Shanghai General Hospital) 相关的临床试验The Safety and Efficacy for Anti-human CLL-1 CAR-NK Cells in Subjects With Relapsed/Refractory Acute Myeloid Leukemia
This study is a single-arm, open-label, dose-escalation clinical trial aimed at exploring the safety, tolerability, and pharmacokinetic characteristics of the CLL-1 CAR NK cells, as well as providing preliminary observations on its efficacy in subjects with relapsed/refractory acute myeloid leukemia.
100 项与 CLL-1 CAR-NK Cell(Shanghai General Hospital) 相关的临床结果
100 项与 CLL-1 CAR-NK Cell(Shanghai General Hospital) 相关的转化医学
100 项与 CLL-1 CAR-NK Cell(Shanghai General Hospital) 相关的专利（医药）
100 项与 CLL-1 CAR-NK Cell(Shanghai General Hospital) 相关的药物交易
